These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7057394)

  • 1. Characterization of vasopressin analgesia.
    Berkowitz BA; Sherman S
    J Pharmacol Exp Ther; 1982 Feb; 220(2):329-34. PubMed ID: 7057394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats.
    Feuerstein G; Zerbe RL; Faden AI
    J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationship between central bradykinin and vasopressin in conscious rats.
    Brooks DP; Share L; Crofton JT; Nasjletti A
    Brain Res; 1986 Apr; 371(1):42-8. PubMed ID: 3754782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin analgesia: specificity of action and non-opioid effects.
    Kordower JH; Bodnar RJ
    Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure and heart rate effect of a vasopressin antagonist in conscious normotensive rats pretreated with exogenous vasopressin.
    Waeber B; Nussberger J; Brunner HR
    Eur J Pharmacol; 1983 Jul; 91(1):135-7. PubMed ID: 6688586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal vasopressin administration alters efferent renal nerve activity.
    Riphagen CL; Pittman QJ
    Proc West Pharmacol Soc; 1987; 30():175-7. PubMed ID: 3628272
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
    Burnier M; Biollaz J; Brunner DB; Gavras H; Brunner HR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):222-7. PubMed ID: 6129318
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenylephrine-induced antinociception: investigations of potential neural and endocrine bases.
    Watkins LR; Thurston CL; Fleshner M
    Brain Res; 1990 Oct; 528(2):273-84. PubMed ID: 2271928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitated secretion of pressor amounts of vasopressin in spontaneously hypertensive rats.
    Iriuchijima J
    Hiroshima J Med Sci; 1984 Dec; 33(4):571-5. PubMed ID: 6549509
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of intrathecal vasopressin-induced antinociception, scratching behavior, and motor suppression.
    Thurston CL; Campbell IG; Culhane ES; Carstens E; Watkins LR
    Peptides; 1992; 13(1):17-25. PubMed ID: 1535707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid.
    Aydin C; Yalcin M
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of dPTyr(Me)AVP, a vasopressin antagonist, upon foot shock analgesia.
    Kordower JH; Bodnar RJ
    Int J Neurosci; 1985 Dec; 28(3-4):269-78. PubMed ID: 3005187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitisation to central cardiovascular effects of angiotensin II in rats with a myocardial infarct: relevance to stress and interaction with vasopressin.
    Cudnoch-Jedrzejewska A; Szczepanska-Sadowska E; Dobruch J; Puchalska L; Ufnal M; Kowalewski S; Wsół A
    Stress; 2008 Jul; 11(4):290-301. PubMed ID: 18574789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.
    Solomon RE; Brody MJ; Gebhart GF
    J Pharmacol Exp Ther; 1989 Oct; 251(1):27-38. PubMed ID: 2571720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo apparent peptide-receptor dissociation rate constants for arginine vasopressin analogs estimated from inhibition of rat pressor responses.
    Gazis D
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2099-103. PubMed ID: 2827873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin and stress-induced antinociception in the mouse.
    Hart SL; Oluyomi AO
    Br J Pharmacol; 1990 Feb; 99(2):243-6. PubMed ID: 2328392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis.
    Berson BS; Berntson GG; Zipf W; Torello MW; Kirk WT
    Endocrinology; 1983 Jul; 113(1):337-43. PubMed ID: 6861706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothermia induced by centrally administered vasopressin in rats. A structure-activity study.
    Meisenberg G; Simmons WH
    Neuropharmacology; 1984 Oct; 23(10):1195-200. PubMed ID: 6549207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical syntheses and biological studies on dimeric chimeras of oxytocin and the V(2)-antagonist, d(CH(2))(5)[D-Ile(2), Ile(4)]arginine vasopressin.
    Chen L; Golser R; Machová A; Slaninová J; Barany G
    J Med Chem; 1999 Dec; 42(24):5002-9. PubMed ID: 10585209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lack of 'sensitization' to the pressor effects of centrally injected vasopressin in rats.
    Lawrence D; Pittman QJ
    Brain Res; 1985 May; 334(1):157-9. PubMed ID: 3995307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.